sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseIT, Software & Telecom

Neurology Software Market Projected at USD 12411 million by 2034 on 12.24% Annual Growth

North America leads with 42% of 2025 revenue, while Clinical Decision Support and AI Analytics Software grows fastest at 20.23% across the forecast period.

PUNE, INDIA — 26 SEPTEMBER 2026 — CONTRIVE DATUM INSIGHTS

Market reaches USD 12411 million by 2034, up from USD 4300 million in 2025, at a 12.24% CAGR.

North America holds 42% of 2025 revenue at USD 1806 million.

Fastest growth: Clinical Decision Support and AI Analytics Software at 20.23% a year.

32% of 2025 revenue sits in Diagnostic and Imaging Analysis Software, the largest software type line.

The global neurology software market was valued at USD 4300 million in 2025. The market is projected to grow from USD 4925 million in 2026 to USD 12411 million by 2034, exhibiting a compound annual growth rate of 12.24% during the forecast period. Contrive Datum Insights presents this information in its report titled "Neurology Software Market Size, Share & Industry Analysis, By Software type (Diagnostic and Imaging Analysis Software, Neurophysiological Monitoring Software (EEG/EMG), Electronic Health Record (EHR) and Practice Management Software, Teleneurology and Remote Monitoring Platforms, Clinical Decision Support and AI Analytics Software), Deployment model (Cloud-Based / SaaS, On-Premise, Hybrid), End user (Hospitals, Specialty Neurology Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Other Care Settings), Application (Stroke Management, Epilepsy Management, Movement Disorders, Dementia and Alzheimer's Care, Other Neurological Conditions), Component (Software, Services), and Regional Forecast, 2026-2034".

Neurology software refers to clinical applications used to capture, analyze, store and act on neurological patient data, spanning electronic health record modules built specifically for neurology workflows, software that interprets electroencephalogram and electromyogram signals, platforms that assist radiologists and neurologists in reading brain and spine imaging, and remote monitoring tools that let care teams track patients with stroke, epilepsy, movement disorders or dementia outside the hospital. Buyers include hospital neurology departments, standalone neurology and neurophysiology clinics, diagnostic imaging centers and, increasingly, primary care and telehealth networks referring patients into neurological care pathways.

Rising hospital adoption of AI-assisted neurological diagnostic and monitoring software

Rising hospital adoption of AI-assisted neurological diagnostic and monitoring software is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 12.24% a year, the software type lines exposed to it move fastest: Clinical Decision Support and AI Analytics Software compounds at 20.23%, taking its share of revenue from 11% to 21% and its value from USD 473 million to USD 2606 million.

On the upside, the study's bull case assumes bull case assumes AI-assisted diagnostic tools clear regulatory review faster than the base case and hospitals accelerate cloud migration to capture productivity gains sooner, which would take 2034 revenue to USD 14087 million against the USD 12411 million base case.

The downside is specific. Bear case assumes reimbursement policy for AI-assisted diagnostic tools tightens and hospital IT budgets prioritize other clinical software ahead of neurology-specific platforms, and 2034 revenue lands at USD 10959 million. Diagnostic and Imaging Analysis Software is the drag, 32% of the 2025 base compounding at 10.15% while the market runs at 12.24%.

What Else the Report Shows

SegmentLed 2025 byShare & valueFastest-growing
Software typeDiagnostic and Imaging Analysis Software32% · USD 1376 million—
Deployment modelCloud-Based / SaaS58% · USD 2494 million—
End userHospitals48% · USD 2064 millionSpecialty Neurology Clinics 13.87%
ApplicationStroke Management30% · USD 1290 millionDementia and Alzheimer's Care 15.32%
ComponentSoftware72% · USD 3096 millionServices 14.18%
  • North America was the largest region in 2025, holding 42% of global revenue at USD 1806 million and reaching USD 4716 million by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 22% in 2025 to 27% in 2034, with revenue growing from USD 946 million to USD 3351 million.
  • Middle East and Africa remains the smallest region throughout, at 4% of 2025 revenue and 4% by 2034.
  • Clinical Decision Support and AI Analytics Software is projected to grow at 20.23% over the forecast period, the fastest of any software type line.
  • The United States is the largest single country market at USD 1589 million in 2025, 36.95% of global revenue.

Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by software type, and by deployment model, end user, application and component. The headline total carries bear, base and bull cases at USD 10959 million and USD 14087 million by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078